Ann: Quarterly Activities and Cashflow Report, page-5

Spot on and the very reason i believe INK is on the cusp of finally turning numerous global trials into a major revenue and profit opportunity. I have kept an eye on this stock a long time since the name and focus change. Been a long time coming with extensive trials but i believe INK is now at the pointy end with trial results showing the major potential to increase oil production and reduce viscosity. Low shares on issue plus board with good skin in the game and a tight top 20. All adds up to potential for a major run once we see just 1 trial turn to a revenue generating deal. With numerous global trials though the potential is for numerous deals opening up and INK heading on a major re-rate. Locked and loaded now.